Wednesday, March 4, 2015 | 2:00 PM - 3:00 PM CST
Attendees Will Learn:
With an earlier warning of developing pathology and deteriorating patient conditions—in advance of other systemic measures—clinicians can intervene sooner and avoid a wide range of adverse patient outcomes. In this presentation, we’ll discuss:
- A high-acuity cardiac patient story: Undetected hypoxia and ischemia and the financial impact to the hospital
- Value-based healthcare and how site-specific perfusion monitoring technology may be evaluated for its potential economic impact and/or cost savings through reduced risk of:
-
-
-
-
-
- major organ morbidity or mortality (1,2)
- post-operative cognitive decline (3)
- prolonged time on mechanical ventilation (1,2)
- lengthy ICU and hospital stays (1,2,3)
-
-
-
-
-
- A cardiac surgeon’s perspective on bridging the gap between clinical and administrative responsibilities
- Covidien’s retrospective multi-site study currently underway to measure the clinical and financial impact of using INVOSTM Sytem’s rSO2 monitoring versus not using it.
- Goldman, Scott M. et al. Outcome Improvement and Cost Reduction in an Increasingly Morbid Cardiac Surgery Population. Semin Cardiothorac Vasc Anesth 2006;10:171-175.
- Murkin, John M. et al. Monitoring Brain Oxygen Saturation During Coronary Bypass Surgery: A Randomized, Prospective Study. Anesth Analg 2007;104:51–8.
- Slater, James P. et al. Cerebral Oxygen Desaturation Predicts Cognitive Decline and Longer Hospital Stay After Cardiac Surgery. Ann Thorac Surg 2009;87:36–45.
Guest Speaker:
Corporate Presenters:
